Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 29, 2022 1:24pm
190 Views
Post# 34374757

RE:Aristotle appointments gone for this week

RE:Aristotle appointments gone for this week60 appointments down to 28 for next week.  More than half gone.  

No idea if the calls result in purchased tests but decent interest.

If the 60 appontments per week generate even 1/3 or 20 sales thats $40,000 a week in revenue roughly $500,000 a month.

zzzzzzzzzzzzzzzzz back to no news as usual.



LithLover wrote: 60 spots open for next week.  Also looks like there are 3 spots open for next Wednesday at 7 am, did they hire another case manager.

Interesting only 1 appointment for tomorrow Jan 27 and 1 on Monday Jan 31 (sorry as I was typing tomorrows is now gone)

For next week there are 60 appointments available.  Note that for next Wednesday at 7:00 am there are 3 spots.  Looks like they hired another case manager.

https://careoncology.com/reserve-a-call-with-a-case-manager/ 


<< Previous
Bullboard Posts
Next >>